SymbolANPCF
NameCELLBXHEALTH PLC
SectorUNDEFINED
RegionEurope
Industry-
AddressGU2 7AF United Kingdom ENG 10 Nugent Road Surrey Research Park, Guildford
Telephone+44 1483 343434
Fax
Email
Websitehttp://www.cellbxhealthcom
IncorporationGB
Incorporated On2004
Employees
Fiscal Year12/31
Public Since
ExchangesOTC
AuditorPricewaterhouseCoopers LLP;
Audit StatusAUDITED
Reporting StatusInternational Reporting: LSE - London Stock Exchange
CIK0001620678
Description

CelLBxHealth plc (formerly ANGLE plc) is a global precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be seamlessly integrated with existing laboratory instruments for comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows. Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs* and clinical lab partnerships. (2) Lab Developed Tests (LDTs): Strategic partnerships combined with a focused in-house development programme (3) Laboratory services: Clinical trial support and assay development. The product portfolio comprises the Parsortix® platform with associated consumables and assays. Laboratory services are delivered from CelLBxHealth’s GCLP certified UK laboratory, providing bespoke clinical-trial support and assay development. For more information, visit www.cellbxhealth.com.

Additional info from OTC:
CelLBxHealth plc (formerly ANGLE plc) is a global precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be seamlessly integrated with existing laboratory instruments for comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows. Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs* and clinical lab partnerships. (2) Lab Developed Tests (LDTs): Strategic partnerships combined with a focused in-house development programme (3) Laboratory services: Clinical trial support and assay development. The product portfolio comprises the Parsortix® platform with associated consumables and assays. Laboratory services are delivered from CelLBxHealth’s GCLP certified UK laboratory, providing bespoke clinical-trial support and assay development. For more information, visit www.cellbxhealth.com.

2025-10-30 08:36

OTCQB symbol attribute type Security_Name was changed. Previous value: ANGLE PLC ORD. New value: CELLBXHEALTH PLC.

Read more
2024-08-27 14:31

OTCQX International symbol attribute type Security_Name was changed. Previous value: -. New value: ANGLE PLC ORD.

Read more
2024-08-27 08:16

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: ANGLE PLC ORD.

Read more